Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis - Wu, Un-In; Chen, Wan-Chin; Yang, Ching-Shiang; Wang, Jiun-Ling; Hu, Fu-Chang; Chang, Shan-Chwen; Chen, Yee-Chun (International journal of infectious diseases, 2012)
Keywords: adults; Aged; Anti-Bacterial Agents - therapeutic use; Bacteremia; Bacteremia - drug therapy; Bacteremia - mortality; beta-Lactamases - biosynthesis; beta-Lactams - therapeutic use; Carbapenems - pharmacology; drug therapy; Ertapenem; ESBL; Escherichia coli; Escherichia coli - isolation & purification; Escherichia coli - pathogenicity; Female; Humans; imipenem; Imipenem - therapeutic use; Infectious Disease; Male; males; meropenem; Middle Aged; Mortality; patients; Propensity Score; prospective studies; Pseudomonas aeruginosa; Pulmonary/Respiratory; regression analysis; risk; Thienamycins - therapeutic use; ESBL; Ertapenem; Escherichia coli; Mortality; Bacteremia